Literature DB >> 19879521

Assessment and management of bleeding in the first trimester of pregnancy.

B J Snell1.   

Abstract

Vaginal bleeding occurs in 15% to 25% of early pregnancies. While 50% of women who have vaginal bleeding in the first trimester of pregnancy will continue to have a viable pregnancy, the event creates significant anxiety for the woman and can be managed in a multitude of ways. The 3 main differential diagnoses associated with vaginal bleeding are spontaneous abortion, ectopic pregnancy, and gestational trophoblastic disease. This article reviews early pregnancy development, etiologies of vaginal bleeding in the first trimester, strategies for evaluation, and recognition and management of the main diagnostic considerations. Case study examples illustrating the complexity of the assessment and management of vaginal bleeding in early pregnancy are presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879521     DOI: 10.1016/j.jmwh.2009.08.007

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  4 in total

1.  Cervical shock: a complication of incomplete abortion.

Authors:  Julian David Birch; Divyansh Gulati; Sachin Mandalia
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Management approach of a postmenopausal woman with a completely massive molar pregnancy: A case report.

Authors:  Abdikarim Ali Omar; Ahmed Issak Hussein; Hiba Bashir Hassan; Khadija Yusuf Ali
Journal:  Ann Med Surg (Lond)       Date:  2022-06-30

3.  Maternal and perinatal outcomes in pregnant women with first trimester vaginal bleeding.

Authors:  Zhila Amirkhani; Meisam Akhlaghdoust; Media Abedian; Gelareh Rabie Salehi; Nesa Zarbati; Maryam Mogharehabed; Sahba Arefian; Mina Jafarabadi
Journal:  J Family Reprod Health       Date:  2013-06

4.  An outcomes evaluation of an emergency department early pregnancy assessment service and early pregnancy assessment protocol.

Authors:  Kim Wendt; Julia Crilly; Chris May; Kym Bates; Rakhee Saxena
Journal:  Emerg Med J       Date:  2013-10-17       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.